Table 2.
Tissue | Disease | Characteristics | Approach | Reference Nos. |
---|---|---|---|---|
Brain | Parkinson’s disease | Defects in mitophagy, reduced mitochondrial biogenesis and mitochondrial dysfunction. Loss of dopaminergic neurons. | Increase or restore mitophagy | 21, 82, 134, 159, 225, 300 |
Alzheimer’s disease | Accumulation of dysfunctional mitochondria, formation of Aβ plaques and neurofibrillary tangles. Loss of neurons and synapses. | Increase autophagy/mitophagy | 128, 162, 166, 177, 210, 333, 334 | |
Huntington disease | Misfolding of Htt leading to formation of cytotoxic aggregates. Defects in autophagy cargo recognition and inhibition of micromitophagy. Accumulation of damaged mitochondria and increased cell death. | Increase autophagy and mitophagy | 111, 178, 242, 255 | |
Amyotrophic lateral sclerosis | Mutations in genes linked to regulation of autophagy/mitophagy. Decreased mitophagy and loss of motor neurons. | Increase autophagy or restore mitophagy | 132, 194, 247, 321 | |
Heart | Myocardial infarction | Mitophagy is activated in response to ischemic/energetic stress. Impaired mitophagy leads to accumulation of damaged mitochondria, loss of myocytes, and heart failure development. | Increase mitophagy | 112, 147, 267, 309 |
Pressure overload | Autophagy and mitophagy are increased during the acute phase of pressure overload but decreased in the chronic phase. Decreased mitophagy correlates with accumulation of dysfunctional mitochondria and cardiac dysfunction. | Increase mitophagy | 18, 98, 264 | |
Doxorubicin-induced cardiotoxicity | Controversial studies have reported both recued and increased mitophagy after exposure to the drug. | Unclear | 105, 109 | |
Various tissues | Cancer | Mitophagy functions as a tumor suppressor mechanism in certain cancers. Impaired mitophagy correlates with enhanced cancer development. | Unclear | 39, 50, 71, 78, 163, 259, 305, 340 |
Lungs | Acute lung injury | Increased mitophagy protects lung cells against hyperoxia, S. aureus infection and sepsis. | Increase autophagy/mitophagy | 175, 286, 343 |
Chronic obstructive pulmonary disease | Controversial: insufficient mitophagy leads to senescence of lung epithelial cells, while enhanced mitophagy leads to activation of necroptosis in lung epithelial cells. Both conditions contribute to COPD. | Unclear | 115, 193 | |
Idiopathic pulmonary fibrosis | Alteration in mitophagy is cell dependent. | Unclear | 6, 137, 154, 224 | |
Increased mitophagy in alveolar macrophages leads to apoptosis resistance and increased inflammation. Reduced mitophagy in fibroblasts enhances the fibrotic response. | ||||
Liver | Alcoholic liver disease and acetaminophen overdose | Activation of autophagy and mitophagy protect against mitochondrial damage and liver injury. | Increase autophagy/mitophagy | 204, 208, 318 |
Immune system | Inflammation | Impaired autophagy/mitophagy leads to the reduced elimination of pathogens. Impaired mitophagy also leads to excess NLRP3 inflammasome activation and chronic inflammation. | Increase autophagy/mitophagy | 4, 131, 176, 190, 198, 344, 345 |
COPD, chronic obstructive pulmonary disease.